Citigroup Inc Biote Corp. Transaction History
Citigroup Inc
- $217 Billion
- Q3 2025
A detailed history of Citigroup Inc transactions in Biote Corp. stock. As of the latest transaction made, Citigroup Inc holds 3,408 shares of BTMD stock, worth $8,588. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,408
Previous 19,607
82.62%
Holding current value
$8,588
Previous $78,000
87.18%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding BTMD
# of Institutions
87Shares Held
15.4MCall Options Held
0Put Options Held
0-
325 Capital LLC New York, NY4.55MShares$11.5 Million4.62% of portfolio
-
Bandera Partners LLC New York, NY2.28MShares$5.76 Million3.0% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$4.04 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.43MShares$3.6 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA695KShares$1.75 Million0.0% of portfolio
About biote Corp.
- Ticker BTMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 7,574,270
- Market Cap $19.1M
- Description
- biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...